Merge Healthcare
About Us Press Room Investor Relations Human Resources Contact Us
Press Room
 
Merge Healthcare
Merge eMed

Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com

Rich Linden, President & CEO
Merge Healthcare
(414) 977-4000
rlinden@merge.com

Attention: Business/Financial Editors:

MERGE EMED TO SHOWCASE ADVANCED SUPPORT FOR DIGITAL ORTHOPAEDIC PLANNING AT THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS® (AAOS)

  • Merge eMed to introduce new digital solutions for surgeons and technologists designed to provide advanced support for orthopaedic planning and diagnosis
  • Solutions designed to address clinical need for highly flexible workflow that can be customized for different planning methodologies
  • Solutions to include Cedara OrthoWorks Planner™, Cedara OrthoWorks Web Planner™, Cedara OrthoWorks Spine Analyzer™ and the award winning Cedara OrthoWorks Care Manager™
  • Offering to provide complimentary support to Merge eMed’s popular imaging solutions eFilm Workstation, FUSION PACS and FUSION Matrix PACS.

Milwaukee, WI, March 16, 2006 – Merge eMed, a Merge Healthcare company (NASDAQ: MRGE; TSX: MRG) and a leader in healthcare software and services, today announced plans to showcase advanced support for digital orthopaedic planning at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS).

Included in the portfolio of solutions will be a wide array of solutions designed to allow 2D and 3D planning over the web, implant selection, templating, as well as tools for tracking and analyzing implant usage, pain thresholds, recovery rates, outcome statistics. Among the solutions demonstrated will be OrthoWorks Planner, OrthoWorks Web Planner, OrthoWorks Spine Analyzer and OrthoWorks Care Manager.

OrthoWorks Planner includes highly customizable workflow that can be adjusted to directly mimic the way that surgeons plan using grease pencils and film. Exceeding wizard level customizations, Planner can be configured to allow different surgeons on the same network to plan in completely different ways. To address different approaches in areas such as leg length discrepancy, image layout, button configurations and planning methodologies can be easily altered to accommodate pelvic or full leg standing x-ray methodologies.

“OrthoWorks represents an evolution to our orthopaedic offering,” said David Noshay, President of Merge eMed. “From dedicated functionality for spine analysis to integrated capabilities for implant performance tracking, OrthoWorks provides comprehensive support for surgeons working in joint arthroplasty, trauma, and deformity corrections.”

Cedara OrthoWorks joins Merge eMed’s other popular medical imaging solutions eFilm Workstation, FUSION PACS and FUSION Matrix PACS.

Merge eMed will debut this new digital technology during AAOS 2006 from March 22-24, at booth 2455 in the South Hall of McCormick Place in Chicago, Illinois.

Merge eMed is a Merge Healthcare company focused on accelerating productivity for radiology departments and specialty practices, imaging centers and hospitals. By combining sophisticated RIS, PACS, advanced visualization and clinical imaging applications, Merge eMed delivers integrated end-to-end software solutions and professional services that are transforming the way our customers interact with referring physicians, manage their workflow, position their businesses in their markets and deliver imaging and information services to their customers. For additional information, visit our website at www.merge-emed.com.

Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. With over twenty years of leadership in the medical imaging and healthcare information technology markets, Merge Healthcare provides innovative solutions for both OEM and the end-user healthcare markets. We custom engineer clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.

"American Academy of Orthopaedic Surgeons" is a registered trademark of the American Academy of Orthopaedic Surgeons.
All other trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.

Press Contact

Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214

Phone:
1-(414) 977-4254

Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.